| __timestamp | Cytokinetics, Incorporated | Geron Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 16758000 |
| Thursday, January 1, 2015 | 19667000 | 17793000 |
| Friday, January 1, 2016 | 27823000 | 18761000 |
| Sunday, January 1, 2017 | 36468000 | 19287000 |
| Monday, January 1, 2018 | 31282000 | 18707000 |
| Tuesday, January 1, 2019 | 39610000 | 20893000 |
| Wednesday, January 1, 2020 | 52820000 | 25678000 |
| Friday, January 1, 2021 | 96803000 | 29665000 |
| Saturday, January 1, 2022 | 177977000 | 43628000 |
| Sunday, January 1, 2023 | 173612000 | 69135000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing costs is crucial for success. Over the past decade, Cytokinetics, Incorporated and Geron Corporation have demonstrated contrasting strategies in handling their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Cytokinetics saw a staggering 900% increase in SG&A expenses, peaking in 2022. This surge reflects their aggressive expansion and investment in research and development. In contrast, Geron Corporation maintained a more conservative approach, with a 300% increase over the same period, indicating a focus on steady growth and cost efficiency. The year 2023 marked a pivotal point, with Cytokinetics slightly reducing their expenses by 2.5%, while Geron continued to rise by 58%. These trends highlight the dynamic nature of cost management in the biotech industry, where strategic financial planning can make or break a company's future.
AbbVie Inc. and Cytokinetics, Incorporated: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation